ITB-Iplus/GDF-MED/2025/1_Annex D. i+solutions model Long-Term Agreement
ITB-Iplus/GDF-MED/2025/1 _Annex C. List of priority countries for TB medicines registration updated
ITB-Iplus/GDF-MED/2025/1 _Annex B - List and technical specifications of products requested
ITB-Iplus/GDF-MED/2025/1_Annex A. Financial Bid Response Form
ITB-Iplus/GDF-MED/2025/1_ITB document pretomanid 200mg
TPMAT Recommendations - Round 30 (EOI Released February 2025)
2025-01_QA Notice_USFDA Warning letter_Mylan Indore Pithampur site
ITB document ITB-Iplus/GDF-MED/2024/3
Annex L. TB medicines target prices ITB-Iplus/GDF-MED/2024/3
Annex K. Form for Requests for Clarifications or Complaints ITB-Iplus/GDF-MED/2024/3